Anti-inflammatory effect of platelet-rich plasma on nucleus pulposus cells with response of TNF-α and IL-1

Journal of Orthopaedic Research

Volumn 32, Issue 4, 2014, Pages 551-556

  Kim, Ho Joong ^a,b   Yeom, Jin S ^a,b   Koh, Yong Gon ^c   Yeo, Jee Eun ^c   Kang, Kyoung Tak ^c   Kang, Young Mi ^d   Chang, Bong Soon ^e   Lee, Choon Ki ^e  

^a Seoul National University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Yonsei Sarang Hospital   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

^e Seoul National University Hospital   (South Korea)

Author keywords

interleukin 1; nucleus pulposus cell; platelet rich plasma; tumor necrosis factor

Indexed keywords

INTERLEUKIN-1; NUCLEUS PULPOSUS CELL; PLATELET-RICH PLASMA; TUMOR NECROSIS FACTOR-Α;

COLLAGEN TYPE II; CYCLOOXYGENASE 2; DOWN-REGULATION; HEALTHY VOLUNTEERS; HUMANS; INTERLEUKIN-1BETA; INTERVERTEBRAL DISC DEGENERATION; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; PLATELET-RICH PLASMA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84893820518     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22532     Document Type: Article

References (38)

1. Ames BN, Shigenaga MK, Hagen TM., 1993. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 90: 7915-7922. (Pubitemid 23260825)
2. Loeser RF., 2010. Age-related changes in the musculoskeletal system and the development of osteoarthritis. Clin Geriatr Med 26: 371-386.
3. Kirkaldy-Willis WH, Wedge JH, Yong HK, et al. 1978. Pathology and pathogenesis of lumbar spondylosis and stenosis. Spine 3: 319-328.
4. Farfan HF, Huberdeau RM, Dubow HI., 1972. Lumbar intervertebral disc degeneration: the influence of geometrical features on the pattern of disc degeneration-a post mortem study. J Bone Joint Surg Am 54: 492-510.
5. Hangai M, Kaneoka K, Kuno S, et al. 2008. Factors associated with lumbar intervertebral disc degeneration in the elderly. Spine J 8: 732-740.
6. Anderson DG, Tannoury C., 2005. Molecular pathogenic factors in symptomatic disc degeneration. Spine J 5: 260S-266S. (Pubitemid 41700070)
7. Ahsan R, Tajima N, Chosa E, et al. 2001. Biochemical and morphological changes in herniated human intervertebral disc. J Orthop Sci 6: 510-518. (Pubitemid 34019559)
8. Roberts S, Caterson B, Menage J, et al. 2000. Matrix metalloproteinases and aggrecanase: their role in disorders of the human intervertebral disc. Spine 25: 3005-3013.
9. Cassinelli EH, Hall RA, Kang JD., 2001. Biochemistry of intervertebral disc degeneration and the potential for gene therapy applications. Spine J 1: 205-214. (Pubitemid 33376281)
10. Kang JD, Stefanovic RM, McIntyre LA, et al. 1997. Toward a biochemical understanding of human intervertebral disc degeneration and herniation. Contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases. Spine 22: 1065-1073. (Pubitemid 27209346)
11. Le Maitre CL, Freemont AJ, Hoyland JA., 2005. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 7: R732-R745.
12. Hoyland JA, Le Maitre CL, Freemont AJ., 2008. Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology 47: 809-814. (Pubitemid 351796365)
13. Weiler C, Nerlich AG, Bachmeier BE, et al. 2005. Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls. Spine 30: 44-53. (Pubitemid 40209276)
14. Sguin CA, Pilliar RM, Roughley PJ, et al. 2005. Tumor necrosis factor-alpha modulates matrix production and catabolism in nucleus pulposus tissue. Spine 30: 1940-1948. (Pubitemid 41292217)
15. Shinmei M, Kikuchi T, Yamagishi M, et al. 1988. The role of interleukin-1 on proteoglycan metabolism of rabbit annulus fibrosus cells cultured in vitro. Spine 13: 1284-1290. (Pubitemid 19007060)
16. Jenis LG, Banco RJ, Kwon B., 2006. A prospective study of Autologous Growth Factors (AGF) in lumbar interbody fusion. Spine J 6: 14-20. (Pubitemid 43079169)
17. Mehta S, Watson JT., 2008. Platelet rich concentrate: basic science and current clinical applications. J Orthop Trauma 22: 432-438.
18. Alsousou J, Thompson M, Hulley P, et al. 2009. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg Br 91: 987-996.
19. Eppley BL, Woodell JE, Higgins J., 2004. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg 114: 1502-1508. (Pubitemid 40361959)
20. Chen W, Lo W, Lee J, et al. 2006. Tissue-engineered intervertebral disc and chondrogenesis using human nucleus pulposus regulated through TGF-beta1 in platelet-rich plasma. J Cell Physiol 209: 744-754. (Pubitemid 44665697)
21. Wu C, Chen W, Zao B, et al. 2011. Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. Biomaterials 32: 5847-5854.
22. Woodell May J, Matuska A, Oyster M, et al. 2011. Autologous protein solution inhibits MMP-13 production by IL-1β and TNF-α stimulated human articular chondrocytes. J Orthop Res 29: 1320-1326.
23. Thompson J, Pearce R, Schechter M, et al. 1990. Preliminary evaluation of a scheme for grading the gross morphology of the human intervertebral disc. Spine 15: 411-415. (Pubitemid 20188043)
24. van Buul GM, Koevoet WLM, Kops N, et al. 2011. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. Am J Sports Med 39: 2362-2370.
25. Studer RK, Vo N, Sowa G, et al. 2011. Human nucleus pulposus cells react to IL-6: independent actions and amplification of response to IL-1 and TNF-α. Spine 36: 593-599.
26. Bendinelli P, Matteucci E, Dogliotti G, et al. 2010. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF. J Cell Physiol 225: 757-766.
27. Bachmeier BE, Nerlich AG, Weiler C, et al. 2007. Analysis of tissue distribution of TNF-α, TNF-α-receptors, and the activating TNF-α-converting enzyme suggests activation of the TNF-α system in the aging intervertebral disc. Ann N Y Acad Sci 1096: 44-54. (Pubitemid 47092497)
28. Akeda K, An HS, Pichika R, et al. 2006. Platelet-rich plasma (PRP) stimulates the extracellular matrix metabolism of porcine nucleus pulposus and anulus fibrosus cells cultured in alginate beads. Spine 31: 959-966. (Pubitemid 43785925)
29. Spreafico A, Chellini F, Frediani B, et al. 2009. Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J Cell Biochem 108: 1153-1165.
30. Matsunaga S, Nagano S, Onishi T, et al. 2003. Age-related changes in expression of transforming growth factor-beta and receptors in cells of intervertebral discs. J Neurosurg 98: 63-67. (Pubitemid 36050485)
31. Drengk A, Zapf A, Strmer EK, et al. 2009. Influence of platelet-rich plasma on chondrogenic differentiation and proliferation of chondrocytes and mesenchymal stem cells. Cells Tissues Organs 189: 317-326.
32. Gaissmaier C, Fritz J, Krackhardt T, et al. 2005. Effect of human platelet supernatant on proliferation and matrix synthesis of human articular chondrocytes in monolayer and three-dimensional alginate cultures. Biomaterials 26: 1953-1960. (Pubitemid 39575337)
33. Demoor FM, Boittin M, Redini F, et al. 1999. Differential effects of interleukin-1 and transforming growth factor beta on the synthesis of small proteoglycans by rabbit articular chondrocytes cultured in alginate beads as compared to monolayers. Mol Cell Biochem 199: 69-80. (Pubitemid 29476144)
34. Chen CW, Tsai YH, Deng WP, et al. 2005. Type I and II collagen regulation of chondrogenic differentiation by mesenchymal progenitor cells. J Orthop Res 23: 446-453. (Pubitemid 40287874)
35. Reid DL, Aydelotte MB, Mollenhauer J., 2000. Cell attachment, collagen binding, and receptor analysis on bovine articular chondrocytes. J Orthop Res 18: 364-373. (Pubitemid 30599611)
36. Cao L, Lee V, Adams ME, et al. 1999. beta-Integrin-collagen interaction reduces chondrocyte apoptosis. Matrix Biol 18: 343-355. (Pubitemid 29397446)
37. Mazzocca AD, McCarthy MBR, Chowaniec DM, et al. 2012. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am 94: 308-316.
38. Sundman EA, Cole BJ, Fortier LA., 2011. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med 39: 2135-2140.